ArticleJournal of translational medicine2018

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma.

David Borg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.